These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19713653)

  • 1. d,l-Sotalol reverses abbreviated atrial refractoriness and prevents promotion of atrial fibrillation in a canine model with left ventricular dysfunction induced by atrial tachypacing.
    Sakamoto T; Fujiki A; Nakatani Y; Sakabe M; Mizumaki K; Hashimoto N; Inoue H
    Circ J; 2009 Oct; 73(10):1820-8. PubMed ID: 19713653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction.
    Sakabe M; Fujiki A; Sakamoto T; Nakatani Y; Mizumaki K; Inoue H
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1130-5. PubMed ID: 22587612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.
    Nakatani Y; Nishida K; Sakabe M; Kataoka N; Sakamoto T; Yamaguchi Y; Iwamoto J; Mizumaki K; Fujiki A; Inoue H
    J Am Coll Cardiol; 2013 Feb; 61(5):582-8. PubMed ID: 23273396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.
    Kataoka N; Nishida K; Kinoshita K; Sakamoto T; Nakatani Y; Tsujino Y; Mizumaki K; Inoue H; Kinugawa K
    Heart Vessels; 2016 Dec; 31(12):2053-2060. PubMed ID: 27236656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillation.
    Tse HF; Lau CP
    J Am Coll Cardiol; 2002 Dec; 40(12):2150-5. PubMed ID: 12505228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation.
    Zhao H; Li T; Liu G; Zhang L; Li G; Yu J; Lou Q; He R; Zhan C; Li L; Yang W; Zang Y; Cheng C; Li W
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):575-585. PubMed ID: 31159577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide.
    Wang J; Feng J; Nattel S
    Circulation; 1994 Oct; 90(4):2032-40. PubMed ID: 7923691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhomogenic effect of bepridil on atrial electrical remodeling in a canine rapid atrial stimulation model.
    Fukaya H; Niwano S; Satoh D; Masaki Y; Niwano H; Kojima J; Moriguchi M; Izumi T
    Circ J; 2008 Feb; 72(2):318-26. PubMed ID: 18219173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.
    He Z; Sun C; Xu Y; Cheng D
    Biomed Pharmacother; 2016 Dec; 84():1760-1767. PubMed ID: 27847200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs.
    Duytschaever M; Blaauw Y; Allessie M
    Cardiovasc Res; 2005 Jul; 67(1):69-76. PubMed ID: 15949471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction.
    Sakabe M; Fujiki A; Nishida K; Sugao M; Nagasawa H; Tsuneda T; Mizumaki K; Inoue H
    J Cardiovasc Pharmacol; 2004 Jun; 43(6):851-9. PubMed ID: 15167279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pilsicainide on atrial electrophysiologic properties in the canine rapid atrial stimulation model.
    Kojima J; Niwano S; Moriguchi M; Ikeda K; Inuo K; Saito J; Izumi T
    Circ J; 2003 Apr; 67(4):340-6. PubMed ID: 12655166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bepridil reverses atrial electrical remodeling and L-type calcium channel downregulation in a canine model of persistent atrial tachycardia.
    Nishida K; Fujiki A; Sakamoto T; Iwamoto J; Mizumaki K; Hashimoto N; Inoue H
    J Cardiovasc Electrophysiol; 2007 Jul; 18(7):765-72. PubMed ID: 17472715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inefficacy of a highly selective T-type calcium channel blocker in preventing atrial fibrillation related remodeling.
    Kato T; Iwasaki YK; Duker G; Fjellstrom O; Giordanetto F; Sundqvist M; Wallin A; Wang QD; Nattel S
    J Cardiovasc Electrophysiol; 2014 May; 25(5):531-536. PubMed ID: 24330029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
    Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
    Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
    Knobloch K; Brendel J; Rosenstein B; Bleich M; Busch AE; Wirth KJ
    Med Sci Monit; 2004 Jul; 10(7):BR221-8. PubMed ID: 15232496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
    Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
    van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.